[HTML][HTML] Developing novel host-based therapies targeting microbicidal responses in macrophages and neutrophils to combat bacterial antimicrobial resistance
Antimicrobial therapy has provided the main component of chemotherapy against bacterial
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
[PDF][PDF] Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance
K Watson, CD Russell, JK Baillie, K Dhaliwal… - Front. Immunol. 11: 786 …, 2020 - core.ac.uk
Antimicrobial therapy has provided the main component of chemotherapy against bacterial
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance
K Watson, CD Russell, JK Baillie… - Frontiers in …, 2020 - research.ed.ac.uk
Antimicrobial therapy has provided the main component of chemotherapy against bacterial
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
Developing novel host-based therapies targeting microbicidal responses in macrophages and neutrophils to combat bacterial antimicrobial resistance
K Watson, CD Russell, JK Baillie… - Frontiers in …, 2020 - eprints.whiterose.ac.uk
Antimicrobial therapy has provided the main component of chemotherapy against bacterial
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
[PDF][PDF] Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance
K Watson, CD Russell, JK Baillie… - Front. Immunol. 11 …, 2020 - scienceopen.com
Antimicrobial therapy has provided the main component of chemotherapy against bacterial
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
[PDF][PDF] Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance
K Watson, CD Russell, JK Baillie, K Dhaliwal… - 2020 - pure.ed.ac.uk
Antimicrobial therapy has provided the main component of chemotherapy against bacterial
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance
K Watson, CD Russell, JK Baillie… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Antimicrobial therapy has provided the main component of chemotherapy against bacterial
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance
K Watson, CD Russell, JK Baillie… - … Combined Host-and …, 2020 - books.google.com
Antimicrobial therapy has provided the main component of chemotherapy against bacterial
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
[HTML][HTML] Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance
K Watson, CD Russell, JK Baillie, K Dhaliwal… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Antimicrobial therapy has provided the main component of chemotherapy against bacterial
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance.
K Watson, CD Russell, JK Baillie, K Dhaliwal… - Frontiers in …, 2020 - europepmc.org
Antimicrobial therapy has provided the main component of chemotherapy against bacterial
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …
pathogens. The effectiveness of this strategy has, however, been increasingly challenged by …